Kisspeptin, encoded by the Kiss1 gene, has attracted attention as a key candidate neuropeptide in controlling puberty and reproduction via regulation of gonadotrophin-releasing hormone (GnRH) secretion in mammals. Pioneer studies with Kiss1 or its cognate receptor Gpr54 knockout (KO) mice showed the indispensable role of kisspeptin-GPR54 signalling in the control of animal reproduction, although detailed analyses of gonadotrophin secretion, especially pulsatile and surge-mode of luteinising hormone (LH) secretion, were limited. Thus, in the present study, we have generated Kiss1 KO rats aiming to evaluate a key role of kisspeptin in governing reproduction via pulse and surge modes of GnRH/LH secretion. Kiss1 KO male and female rats showed a complete suppression of pulsatile LH secretion, which is responsible for folliculogenesis and spermatogenesis, and an absence of puberty and atrophic gonads. Kiss1 KO female rats showed no spontaneous LH/follicle-stimulating hormone surge and an oestrogen-induced LH surge, suggesting that the GnRH surge generation system, which is responsible for ovulation, does not function without kisspeptin. Furthermore, challenge of major stimulatory neurotransmitters, such as monosodium glutamate, NMDA and norepinephrine, failed to stimulate LH secretion in Kiss1 KO rats, albeit they stimulated LH release in wild-type controls. Taken together, the results of the present study confirm that kisspeptin plays an indispensable role in generating two modes (pulse and surge) of GnRH/gonadotrophin secretion to regulate puberty onset and normal reproductive performance. In addition, the present study suggests that kisspeptin neurones play a critical role as a hub integrating major stimulatory neural inputs to GnRH neurones, using newly established Kiss1 KO rats, which serve as a useful model for detailed analysis of hormonal profiles.
Puberty in mammals is timed by an increase in gonadotropin-releasing hormone (GnRH)
secretion. Previous studies have shown involvement of the two neuropeptides,
kisspeptin and neurokinin B (NKB), in controlling puberty onset. Little is known
about the role of the other key neuropeptide, dynorphin, in controlling puberty
onset, although these three neuropeptides colocalize in the arcuate kisspeptin
neurons. The arcuate kisspeptin neuron, which is also referred to as the KNDy neuron,
has recently been considered to play a role as an intrinsic source of the GnRH pulse
generator. The present study aimed to determine if attenuation of inhibitory
dynorphin-kappa-opioid receptor (KOR) signaling triggers the initiation of puberty in
normal developing female rats. The present study also determined if stimulatory
NKB-neurokinin 3 receptor (NK3R) signaling advances puberty onset. Female
Wistar-Imamichi rats were weaned and intraperitoneally implanted with osmotic
minipumps filled with nor-binaltorphimine (nor-BNI), a KOR antagonist, or senktide, a
NK3R agonist, at 20 days of age. Fourteen days of intraperitoneal infusion of nor-BNI
or senktide advanced puberty onset, manifested as vaginal opening and the first
vaginal estrus in female rats. Frequent blood sampling showed that nor-BNI
significantly increased luteinizing hormone (LH) pulse frequency at 29 days of age
compared with vehicle-treated controls. Senktide tended to increase this frequency,
but its effect was not statistically significant. The present results suggest that
the inhibitory input of dynorphin-KOR signaling plays a role in the prepubertal
restraint of GnRH/LH secretion in normal developing female rats and that attenuation
of dynorphin-KOR signaling and increase in NKB-NK3R signaling trigger the onset of
puberty in female rats.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.